Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

  title={Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones},
  author={Anna Rickli and Marius C. Hoener and Matthias E. Liechti},
  journal={European Neuropsychopharmacology},

Figures and Tables from this paper

Pharmacological profile of mephedrone analogs and related new psychoactive substances
Pharmacological profiling of novel psychoactive substances
Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
The conclusion is made that abuse liability for amphetamine-like NPS may be higher than for MDMA- like NPS, but that the risk for developing the life-threatening serotonin syndrome may be increased for ecstasy-likeNPS.
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Monoamine Transporter and Receptor Interaction Profiles of Synthetic Cathinones
There are considerable differences among cathinones with respect to potencies and relative activity at monoaminergic targets, and in vitro screening and pharmacological classification are essential in providing translationally valuable information promptly after new cathinone derivatives emerge among drug users.
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
Interactions of 20 “bath salt” components with human dopamine, serotonin, and norepinephrine transporters heterologously expressed in human embryonic kidney 293 cells suggested thresholds of binding/uptake ratios above which compounds were likely to be substrates.
The synthetic cathinone psychostimulant α-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence.
The results suggest α-PPP has antagonist interactions at 5-HT2A R in vitro that may translate at physiologically-relevant doses in vivo that may contribute to α- PPPs unpopularity compared to other monoamine transporter inhibitors.
Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems
Several metabolites of MDMA, methylone and MDPV interact with human transporters and receptors at pharmacologically relevant concentrations and could contribute to the in vivo activity of the parent compounds in human users.


Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity
The data strongly suggest that the antidepressant activity of quetiapine is mediated, at least in part, by its metabolite N-DesalkylquetiAPine through NET inhibition and partial 5-HT1A agonism.
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes
All psychoactive tryptamines are 5-HT2A agonists, but5-HT transporter (SERT) activity may contribute significantly to the pharmacology of certain compounds, and in vitro transporter data confirm structure-activity trends for releasers and uptake inhibitors whereby releasers tend to be structurally smaller compounds.
Neurochemical profiles of some novel psychoactive substances.
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products
The data show that MDPV is a monoamine transporter blocker with increased potency and selectivity for catecholamines when compared with cocaine, and may provide a mechanism to explain the adverse effects observed in humans taking high doses of ‘bath salts’ preparations.
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
In vitro and in vivo methods demonstrate that designer methcathinone analogs are substrates for monoamine transporters, with a profile of transmitter-releasing activity comparable to MDMA.
Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives.
Relationship between the Serotonergic Activity and Reinforcing Effects of a Series of Amphetamine Analogs
The results suggest that the mechanism for this effect involves a decrease in reinforcing potency and efficacy among monoamine releasing agents when 5-HT releasing potency is increased relative to DA.